Metastatic breast cancer Initial PBS authority application and Supporting information form (PB099)

You must lodge this form for a patient starting initial PBS subsidised treatment with lapatinib for late stage metastatic breast cancer where disease has progressed despite treatment with trastuzumab. Lapatinib is not PBS subsidised when used in combination with Commonwealth subsidised trastuzumab.


Page last updated: 5 May 2016

This information was printed Wednesday 28 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.